跳至主要内容
临床试验/EUCTR2018-000263-92-FR
EUCTR2018-000263-92-FR进行中(未招募)1 期

Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: a multicenter randomized, double-blind study - ALDOCURE

CHU CAE0 个研究点目标入组 1,500 人开始时间: 2018年3月28日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
1,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Male or female; Age > 18 years
  • Elective CABG surgery ± AVR
  • In sinus rhythm
  • Patient signed consent
  • Willing to comply with scheduled visits, as outlined in the protocol
  • French nationality
  • Recipients of the social security regime
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 1500
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 1500

排除标准

  • Contraindications to spironolactone therapy: intolerance, hyperkalemia (>5.0 mmol/L), severe renal dysfunction (defined as an estimated glomerular filtration rate (eGFR) < 30 ml/min (per the Modification of Diet in Renal Disease (MDRD) 4-component study equation). Subjects with serum creatinine =2.5 mg/dl are also excluded even if their eGFR is =30 ml/min), Severe liver dysfunction (Child-Pugh Class 3), patients treated by other potassium sparing medication (except in case of hypokalemia).
  • Patients treated by MRA treatment (spironolactone or eplerenone)
  • Left ventricular ejection fraction < 50% obtained within 6 months prior to V0
  • Mitral valve surgery associated to the CABG
  • Off-pump beating or emergency CABG
  • History of AF or another atrial arrhythmia
  • Presence of antiarrhythmic medication (other than ß-blockers)
  • Previous heart surgery and heart transplant recipient
  • Unstable conditions: angina or acute coronary syndrome or heart failure during the last 3 months, cardiogenic shock
  • Patients included or planning to be included in another medical research protocol
  • Patients unable to complete the protocol follow-up
  • Pregnant or nursing women
  • Adults with protective measures (curatorship or tutorship)

研究者

发起方
CHU CAE

相似试验